Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weijing Sun

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Biologics : Targets & Therapy|December 26, 2013
Ziv-aflibercept in metastatic colorectal cancerAnuj Patel, Weijing Sun
Current Treatment Options in Oncology|May 20, 2014
Molecular targeted therapy in hepatocellular carcinoma: from biology to clinical practice and futureAnuj Patel, Weijing Sun
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Cancers of the large bowel and hepatobiliary tractWeijing Sun, Daniel Haller
Journal of Hematology & Oncology|July 29, 2015
Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting--its impact on clinical practiceGaurav Goel, Weijing Sun
Journal of Hematology & Oncology|July 16, 2015
Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockadeGaurav Goel, Weijing Sun
Oncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan and fixed-dose-rate gemcitabine in advanced pancreatic and biliary cancer: phase I studyWeijing Sun, Daniel Haller
Chinese Journal of Cancer|September 2, 2016
Gastric cancer: current and evolving treatment landscapeWeijing Sun, Li Yan
Chinese Journal of Cancer|September 6, 2014
Cancer immunotherapy in clinical practice -- the past, present, and futureGaurav Goel, Weijing Sun
Journal of Hematology & Oncology|May 4, 2015
Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the futureGaurav Goel, Weijing Sun
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Options for Second-Line Treatment in Metastatic Colorectal CancerJames J Lee, Weijing Sun
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Biologics : Targets & Therapy|December 26, 2013
Ziv-aflibercept in metastatic colorectal cancerAnuj Patel, Weijing Sun
Current Treatment Options in Oncology|May 20, 2014
Molecular targeted therapy in hepatocellular carcinoma: from biology to clinical practice and futureAnuj Patel, Weijing Sun
Cancer Chemotherapy and Biological Response Modifiers|September 2, 2004
Cancers of the large bowel and hepatobiliary tractWeijing Sun, Daniel Haller
Journal of Hematology & Oncology|July 29, 2015
Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting--its impact on clinical practiceGaurav Goel, Weijing Sun
Journal of Hematology & Oncology|July 16, 2015
Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockadeGaurav Goel, Weijing Sun
Oncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan and fixed-dose-rate gemcitabine in advanced pancreatic and biliary cancer: phase I studyWeijing Sun, Daniel Haller
Chinese Journal of Cancer|September 2, 2016
Gastric cancer: current and evolving treatment landscapeWeijing Sun, Li Yan
Chinese Journal of Cancer|September 6, 2014
Cancer immunotherapy in clinical practice -- the past, present, and futureGaurav Goel, Weijing Sun
Journal of Hematology & Oncology|May 4, 2015
Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the futureGaurav Goel, Weijing Sun
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Options for Second-Line Treatment in Metastatic Colorectal CancerJames J Lee, Weijing Sun
Pageof 14